Skip to main content
Anixa Biosciences Inc logo

Anixa Biosciences Inc — Investor Relations & Filings

Ticker · ANIX ISIN · US45069V2034 LEI · 549300PW2C2QTAJL2D19 US Professional, scientific and technical activities
Open in API
Filings indexed 958 across all filing types
Latest filing 2018-03-05 Regulatory Filings
Country US United States of America
Listing US ANIX

About Anixa Biosciences Inc

https://www.anixa.com/

Anixa Biosciences Inc. is a clinical-stage biotechnology company focused on developing therapies and vaccines for the treatment and prevention of cancer. The company's portfolio is centered on two main platforms: a therapeutics program and a vaccine program. The therapeutics portfolio features a Chimeric Antigen Receptor T-cell (CAR-T) immunotherapy, which genetically engineers a patient's own immune cells to target and destroy solid tumors. The vaccine portfolio includes preventative and therapeutic candidates for various cancers, with a primary focus on breast and ovarian cancer, and discovery programs for lung, colon, and prostate cancer. Anixa aims to address critical unmet needs in oncology through these innovative approaches.

Recent filings

Filing Released Lang Actions
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce unscheduled material events or corporate changes. The text specifically mentions the announcement of a strategic alliance with another company and includes a press release as an exhibit. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is short (2777 characters) and serves as a regulatory announcement of an event rather than a detailed report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous SEC filings like Form 8-K that do not fit other specific categories.
2018-03-05 English
Regulatory Filings 2018
Regulatory Filings
2018-02-15 English
SC 13D
Major Shareholding Notification
2018-02-15 English
FORM S-8
Regulatory Filings Classification · 95% confidence The document is a Form S-8 Registration Statement filed with the SEC, which is used to register securities to be offered under employee benefit plans such as stock option plans. It includes detailed information about the securities to be registered, the plan under which they are offered, and the prospectus for resale by certain stockholders. This is a regulatory filing related to securities registration and not a financial report, earnings release, or management discussion. It does not fit into categories like Annual Report, Earnings Release, or Capital/Financing Update. The document is a registration statement under the Securities Act of 1933, which is a regulatory filing. Therefore, the appropriate classification is Regulatory Filings (RNS). The document length is substantial and contains detailed regulatory information, confirming it is not a mere announcement or certification but a full regulatory filing.
2018-02-14 English
DEF 14A
Proxy Solicitation & Information Statement
2018-02-12 English
SC 13G/A
Major Shareholding Notification
2018-01-30 English

Browse filings by year

32 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.